Form 4 holding
President and CEO, Director
CVS HEALTH Corp
- Security class
- Common Stock (By Trust)
- Shares / value
- 431,392
- Estimated value
- $30,091,663
- Report date
- 12 Feb 2024
- Price
- $69.75
- Ownership
- Direct
Karen S. Lynch - President and CEO, Director at CVS HEALTH Corp
Issuer-level insider activity
- Role
- President and CEO, Director
- Issuer ticker
- CVS on NYSE
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Karen S. Lynch since 10 Sep 2025
Reported holdings for Karen S. Lynch in CVS HEALTH Corp
Form 4 holding
President and CEO, Director
CVS HEALTH Corp
- Security class
- Stock Option
- Shares / value
- 188,087
- Estimated value
- $14,964,202
- Report date
- 01 Apr 2024
- Price
- $79.56
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 244,952
Form 4 holding
President and CEO, Director
CVS HEALTH Corp
- Security class
- Common Stock
- Shares / value
- 74,687
- Estimated value
- $5,942,098
- Report date
- 01 Apr 2024
- Price
- $79.56
- Ownership
- Direct
Form 4 holding
President and CEO, Director
CVS HEALTH Corp
- Security class
- Common Stock (Restricted)
- Shares / value
- 45,248
- Estimated value
- $3,599,931
- Report date
- 01 Apr 2024
- Price
- $79.56
- Ownership
- Direct
Form 4 holding
President and CEO, Director
CVS HEALTH Corp
- Security class
- Stock Appreciation Rights
- Shares / value
- 93,989
- Estimated value
- Report date
- 12 Feb 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 93,989
Transaction history for Karen S. Lynch in CVS HEALTH Corp
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.